Master Cancer

Tuition fees for Master Cancer are 292 USD per year.

Master Cancer, offered in French by Université Claude Bernard - Lyon 1 in Lyon, France, is a two-year master's program focused on cancer biology and oncology. This field examines the cellular and molecular mechanisms behind the development and progression of cancer, along with the scientific basis for its diagnosis and treatment. Students typically study cell biology, genetics, and molecular biology as they relate to how normal cells become cancerous, alongside coursework on tumor immunology, cancer pharmacology, and the biological basis of therapies such as chemotherapy, targeted treatments, and immunotherapy. Programs in this area often include training in laboratory research techniques, statistical methods used in clinical and biological research, and the interpretation of scientific literature in oncology. Many also cover topics such as cancer epidemiology, screening, and the translation of laboratory findings into clinical applications, giving students a view of the full pathway from basic research to patient care. Coursework commonly combines lectures and seminars with laboratory work or a research internship, often carried out within a university laboratory or hospital research unit, allowing students to contribute to ongoing cancer research projects. Graduates of cancer biology master's programs typically pursue further study through a doctorate, or move into research roles within academic laboratories, hospitals, pharmaceutical and biotechnology companies, or public health organizations working on cancer prevention and treatment. Instruction for this program is delivered in French, so applicants should be comfortable studying advanced biological science content in that language. The program starts in September and runs over two years, leading to a master's degree. Yearly tuition is 250 EUR. Lyon is home to a significant concentration of hospitals and biomedical research institutions active in cancer research.